This is an excerpt from a story delivered exclusively to Business Insider Intelligence Digital Health Briefing subscribers. To receive the full story plus other insights each morning, click here. In the most recent blow to its health unit, IBM Watson is cutting off sales of its artificial intelligence (AI) drug discovery tool after reporting lagging […]